These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19635412)

  • 1. pHLIP-mediated translocation of membrane-impermeable molecules into cells.
    Thévenin D; An M; Engelman DM
    Chem Biol; 2009 Jul; 16(7):754-62. PubMed ID: 19635412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
    Deacon JC; Engelman DM; Barrera FN
    Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
    Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
    Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
    Wyatt LC; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2811-E2818. PubMed ID: 29507241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
    Andreev OA; Engelman DM; Reshetnyak YK
    Mol Membr Biol; 2010 Oct; 27(7):341-52. PubMed ID: 20939768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effect of pHLIP-amanitin.
    Moshnikova A; Moshnikova V; Andreev OA; Reshetnyak YK
    Biochemistry; 2013 Feb; 52(7):1171-8. PubMed ID: 23360641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.
    Wijesinghe D; Engelman DM; Andreev OA; Reshetnyak YK
    Biochemistry; 2011 Nov; 50(47):10215-22. PubMed ID: 22029270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.
    An M; Wijesinghe D; Andreev OA; Reshetnyak YK; Engelman DM
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20246-50. PubMed ID: 21048084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the insertion properties of pHLIP.
    Musial-Siwek M; Karabadzhak A; Andreev OA; Reshetnyak YK; Engelman DM
    Biochim Biophys Acta; 2010 Jun; 1798(6):1041-6. PubMed ID: 19766589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of pHLIP Technology for Cancer Imaging and Therapy.
    Wyatt LC; Lewis JS; Andreev OA; Reshetnyak YK; Engelman DM
    Trends Biotechnol; 2017 Jul; 35(7):653-664. PubMed ID: 28438340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
    Svoronos AA; Engelman DM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the Membrane Translocation pK of the pH-Low Insertion Peptide.
    Scott HL; Westerfield JM; Barrera FN
    Biophys J; 2017 Aug; 113(4):869-879. PubMed ID: 28834723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP).
    Andreev OA; Engelman DM; Reshetnyak YK
    Chim Oggi; 2009 Mar; 27(2):34-37. PubMed ID: 20037661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of pHLIP to ester and ether lipids.
    Rao BD; Chakraborty H; Chaudhuri A; Chattopadhyay A
    Chem Phys Lipids; 2020 Jan; 226():104849. PubMed ID: 31836521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pHLIP peptide targets nanogold particles to tumors.
    Yao L; Daniels J; Moshnikova A; Kuznetsov S; Ahmed A; Engelman DM; Reshetnyak YK; Andreev OA
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):465-70. PubMed ID: 23267062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant.
    Vasquez-Montes V; Gerhart J; King KE; Thévenin D; Ladokhin AS
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):534-543. PubMed ID: 29138065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ions Modulate Key Interactions between pHLIP and Lipid Membranes.
    Westerfield J; Gupta C; Scott HL; Ye Y; Cameron A; Mertz B; Barrera FN
    Biophys J; 2019 Sep; 117(5):920-929. PubMed ID: 31422821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors.
    Zoonens M; Reshetnyak YK; Engelman DM
    Biophys J; 2008 Jul; 95(1):225-35. PubMed ID: 18359793
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.